Chronic non-A non-B hepatitis treated with interferon
Bjøro, K.; Schrumpf, E.; Elgjo, K.; Nordgård, K.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 110(11): 1346-1348
1990
ISSN/ISBN: 0029-2001 PMID: 2111053 Document Number: 364069
Non-A non-B hepatitis remains a diagnostic and therapeutic problem. Recently published data indicate that interferon may represent a considerable step forward in the therapy of this disease. We have treated a patient with non-A non-B hepatitis with recombinant interferon alpha 2-B. Both biochemical and morphological liver parameters were normalized after nine months of treatment. Further studies are being performed to establish the efficacy and effective doses of interferon in the treatment of non-A non-B hepatitis.
Document emailed within 1 workday
Related Documents
Łapiński, T.W. 2001: Activation of acute phase proteins in patients with chronic hepatitis C treated with interferon-alpha 2a Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(57): 138-142Mauser-Bunschoten, E.P.; Damen, M.; Reesink, H.W.; Roosendaal, G.; Chamuleau, R.A.; van den Berg, H.M. 1996: Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C Annals of Internal Medicine 125(4): 297-299
Daito, K.; Suou, T.; Kawasaki, H. 1994: Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon Research Communications in Chemical Pathology and Pharmacology 83(3): 303-316
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Minelli, R.; Coiro, V.; Valli, M.Antonietta.; Finardi, L.; Di Seclì, C.; Bertoni, R.; La Gioia, D.; Barilli, A.Luciana.; Ferrari, C.; Jotti, G.Saccani.; Delsignore, R. 2005: Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 53(1): 26-30
Rocco, A.; Gargano, S.; Provenzano, A.; Nardone, M.; De Sanctis, G.M.; Altavilla, N.; Chircu, L.V.; Grimaldi, F. 2001: Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection Neuro Endocrinology Letters 22(1): 39-44
Czarnywojtek, A.; Waligórska-Stachura, J.; Szczepanek, E.; Zgorzalewicz-Stachowiak, M.łg.; Bereszyńska, I.; Kurdybacha, P.; Stangierski, A.; Harasymczuk, J.; Florek, E.; Waśko, R.; Ruchała, M. 2012: A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine Neuro Endocrinology Letters 33(3): 268-272
Durante-Mangoni, E.; Iardino, P.; Utili, R.; Adinolfi, L.E.; Ruggiero, G. 2006: Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts Antiviral Therapy 11(5): 637-640
Skiba, E.; Lebensztejn, D.M.; Werpachowska, I.; Kaczmarski, M. 2005: The evaluation of hyaluronic acid and laminin concentration in serum in children with chronic hepatitis B treated with lamivudine, unresponsive to previous interferon-alpha therapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(105): 268-270
Giannoccaro, F.; Pace, L.; Antonaci, S.; Schiraldi, O. 1999: Autoimmune hemolytic anemia in chronic hepatitis C virus infection treated with alpha-interferon: a therapy-related event or extra-hepatic immunologic manifestation? Recenti Progressi in Medicina 90(11): 592-594
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Stancek, D.; Fuchsberger, N.; Oltman, M.; Schmeisser, H.; Kontsek, P.; Jahnová, E.; Hajnická, V. 2001: Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2 Acta Virologica 45(5-6): 287-292
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Kakumu, S.; Ishikawa, T.; Wakita, T.; Yoshioka, K.; Takayanagi, M.; Tahara, H.; Kusakabe, A. 1994: Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B American Journal of Gastroenterology 89(1): 92-96
Fernández, I.; Castellano, G.; Canga, F.; Colina, F.; García, H.; Fuertes, A.; Casis, B.; Martín, A.; Solís, J.A. 1995: A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C Gastroenterologia y Hepatologia 18(2): 66-72